Dr. Jitendra Singh: Tribal Knowledge Meets CRISPR Science
Synopsis
Key Takeaways
When a Union Minister stands before a Janjatiya Gaurav Divas audience and invokes Bhagwan Birsa Munda in the same breath as CRISPR-Cas9 gene therapy, the distance between forest wisdom and frontier science collapses into a single, pointed argument. Union Science and Technology Minister Dr. Jitendra Singh addressed the Ministry of Science and Technology's programme marking Janjatiya Gaurav Divas on Tuesday, 17 November 2026, laying out a vision that positions tribal communities not as passive welfare recipients but as both custodians of India's biodiversity and the intended beneficiaries of its most ambitious biomedical research.
Birsa Munda as the frame for 21st-century inclusion
Bhagwan Birsa Munda, the 19th-century Adivasi leader who led the Ulgulan (great tumult) against colonial exploitation, is not an incidental invocation here. Janjatiya Gaurav Divas was instituted in 2021 to commemorate his birth anniversary on 15 November and to formally recognise tribal contributions to India's freedom struggle and ecological heritage. Dr. Singh framed Munda's legacy as a living mandate — 'his life and contribution continue to inspire efforts towards social justice, equality and inclusive development.'
The minister's remarks placed tribal communities at the intersection of two roles that policy had long treated separately: guardians of forests, rivers and mountains whose ecological knowledge 'continues to inspire modern science', and a population whose health and livelihood deficits demand targeted technological intervention.
CRISPR at the frontier of sickle cell elimination
The sharpest, most consequential signal in Dr. Singh's address was the multi-institutional CRISPR-Cas9 gene therapy effort for sickle cell anaemia — a disease that disproportionately burdens tribal populations across central and eastern India. The collaborative involves CSIR-IGIB (the CSIR Institute of Genomics and Integrative Biology), AIIMS New Delhi, CSIR-IICT Hyderabad, NII Mumbai, and other institutions working collectively toward a potential cure.
The National Sickle Cell Anaemia Elimination Mission, launched in 2023, had already signalled the government's intent to treat the disease as a public-health priority rather than a statistical footnote. CRISPR-based gene editing moves that mission from mass screening into the realm of curative medicine. Dr. Singh was explicit: it is 'this government headed by PM Sh Narendra Modi which has, for the first time, placed both the tribal communities as well as sickle cell anaemia high in its priority list.'
STEM pipelines and technology enterprises in the North East
Beyond the biomedical headline, Dr. Singh sketched a broader economic architecture — one built around digital education, STEM training for tribal youth, and technology-based enterprises supported by 'skills, mentoring, finance and market linkages.' The North Eastern Region received specific mention as a focal geography for this livelihood-creation model.
The emphasis on 'affordable, accessible technologies suited to local conditions and easy to operate and maintain' signals a deliberate pivot away from transplanting urban-centric solutions into Scheduled Areas. The theory of change here is structural: equip tribal youth with scientific skills, anchor them in local enterprise ecosystems, and let them carry India's scientific journey — not as apprentices to the mainstream, but as drivers of it.
India's tribal belt sits atop some of the country's richest biodiversity and some of its deepest development deficits. If CRISPR can close the health gap and STEM pipelines can close the opportunity gap, Janjatiya Gaurav Divas 2026 may be remembered as the moment the government's tribal-science compact moved from policy language into clinical and institutional reality.